Simsen Diagnostics
Simsen Diagnostics is a company that specializes in ultrasensitive sequencing detection of circulating tumor DNA for healthcare and novel applications. They collaborate with partners from academia, the healthcare sector, industries, and governmental authorities to verify technologies and prepare for commercialization. Their technology is designed to detect rare copies from the analysis of DNA sources, particularly circulating tumor DNA. Simsen Diagnostics is a partner in the Sweden’s innovation agency funded project 'Ultrasensitive analysis for improved healthcare and forensics', with a total budget of 56 million SEK. They closely collaborate with Research Institutes of Sweden (RISE) and University of Gothenburg to validate technologies for detecting circulating tumor DNA and immune repertoire sequencing.